Results of a Randomized, Double- Blind, Placebo- Controlled, Phase III Trial of Trifluridine/Tipiracil (TAS-102) Monotherapy in Asian Patients With Previously Treated Metastatic Colorectal Cancer: The TERRA Study

Xu, JM; Kim, TW; Shen, L; Sriuranpong, V; Pan, HM; Xu, RH; Guo, WJ; Han, SW; Liu, TS; Park, YS; Shi, CM; Bai, YX; Bi, F; Ahn, JB; Qin, SK; Li, Q; Wu, CP; Ma, D; Lin, DH; Li, J

Li, J (reprint author), Tongji Univ, Affiliated Shanghai East Hosp, 120 JiMo Rd, Shanghai, Peoples R China.

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (4): 350

Abstract

Purpose Trifluridine/tipiracil (TAS-102) was effective in patients with metastatic colorectal cancer (mCRC) in a phase II Japanese trial. This regiona......

Full Text Link